Paper24487585
Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline.
Bernstein KE and 14 others. J Clin Invest, 2014. Cited by 92 papers, by iCite.
Cite this record
ConductScience Library. Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline. Papers, record 24487585. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24487585
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Amyloid beta-Peptides | Major topic |
| Myeloid Cells | Major topic |
| Peptidyl-Dipeptidase A | Major topic |
| Angiotensin-Converting Enzyme Inhibitors | |
| Animals | |
| Astrocytes | |
| Cell Movement | |
| Cerebral Cortex | |
| Cognition | |
| Female | |
| Humans | |
| Macrophages | |
| Male | |
| Maze Learning | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Transgenic | |
| Plaque, Amyloid | |
| Ramipril | |
| Solubility |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R00 HL088000 | NHLBI NIH HHS | United States | R00HL088000 | PubMed and NIH | NIH RePORTER |
| R01 HL110353 | NHLBI NIH HHS | United States | R01HL110353 | PubMed and NIH | NIH RePORTER |
| UL1 TR000124 | NCATS NIH HHS | United States | UL1TR000124 | PubMed and NIH | NIH RePORTER |
| UL1TR000124 | NCATS NIH HHS | United States | UL1TR000124 | PubMed and NIH | NIH RePORTER |
References79
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21964607 | The carboxypeptidase ACE shapes the MHC class I peptide repertoire. | Nat Immunol | 2011 | https://conductscience.org/library/papers/21964607 | PubMed |
| 2 | 17029828 | Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. | Neurobiol Dis | 2006 | https://conductscience.org/library/papers/17029828 | PubMed |
| 3 | 17973905 | Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy. | Neuropathol Appl Neurobiol | 2008 | https://conductscience.org/library/papers/17973905 | PubMed |
| 4 | 16154999 | Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. | J Biol Chem | 2005 | https://conductscience.org/library/papers/16154999 | PubMed |
| 5 | 11786523 | Mice lacking endothelial angiotensin-converting enzyme have a normal blood pressure. | Circ Res | 2002 | https://conductscience.org/library/papers/11786523 | PubMed |
| 6 | 16491130 | Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease. | Mol Psychiatry | 2006 | https://conductscience.org/library/papers/16491130 | PubMed |
| 7 | 20660248 | Trafficking CD11b-positive blood cells deliver therapeutic genes to the brain of amyloid-depositing transgenic mice. | J Neurosci | 2010 | https://conductscience.org/library/papers/20660248 | PubMed |
| 8 | 10858586 | Inflammation and Alzheimer's disease. | Neurobiol Aging | 2000 | https://conductscience.org/library/papers/10858586 | PubMed |
| 9 | 21969301 | Egr1 expression is induced following glatiramer acetate immunotherapy in rodent models of glaucoma and Alzheimer's disease. | Invest Ophthalmol Vis Sci | 2011 | https://conductscience.org/library/papers/21969301 | PubMed |
| 10 | 19833208 | Inflammation, microglia, and Alzheimer's disease. | Neurobiol Dis | 2010 | https://conductscience.org/library/papers/19833208 | PubMed |
| 11 | 16960575 | Inflammation in Alzheimer disease: driving force, bystander or beneficial response? | Nat Med | 2006 | https://conductscience.org/library/papers/16960575 | PubMed |
| 12 | 12459472 | Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. | FEBS Lett | 2002 | https://conductscience.org/library/papers/12459472 | PubMed |
| 13 | 17687040 | Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition. | J Neurosci | 2007 | https://conductscience.org/library/papers/17687040 | PubMed |
| 14 | 19780903 | Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9. | J Neurochem | 2009 | https://conductscience.org/library/papers/19780903 | PubMed |
| 15 | 19428625 | Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. | Behav Brain Res | 2009 | https://conductscience.org/library/papers/19428625 | PubMed |
| 16 | 1651914 | Transgenic mice demonstrate a testis-specific promoter for angiotensin-converting enzyme. | J Biol Chem | 1991 | https://conductscience.org/library/papers/1651914 | PubMed |
| 17 | 20937811 | Angiotensin-converting enzyme overexpression in mouse myelomonocytic cells augments resistance to Listeria and methicillin-resistant Staphylococcus aureus. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20937811 | PubMed |
| 18 | 15172747 | The microglial phagocytic role with specific plaque types in the Alzheimer disease brain. | Neurobiol Aging | 2004 | https://conductscience.org/library/papers/15172747 | PubMed |
| 19 | 8210185 | Normal and abnormal biology of the beta-amyloid precursor protein. | Annu Rev Neurosci | 1994 | https://conductscience.org/library/papers/8210185 | PubMed |
| 20 | 22737039 | Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where. | Future Neurol | 2012 | https://conductscience.org/library/papers/22737039 | PubMed |
Cited by68
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 92 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42902099 | H3K9me3 inhibition reverses Alzheimer's progression by restoring synaptic and immune proteostasis across the brain-retina axis. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42902099 | PubMed |
| 42666080 | Early Retinal UCHL1 Dysregulation Coupled With Synaptic Loss Reflects Alzheimer's Disease Severity. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42666080 | PubMed |
| 42088504 | Angiotensin-converting enzyme overexpression in mouse neutrophils prevents Alzheimer's-like cognitive decline. | Front Immunol | 2026 | https://conductscience.org/library/papers/42088504 | PubMed |
| 41178713 | Revisiting renin-angiotensin-aldosterone system in aging: translational insights from bench to bedside and back. | J Clin Invest | 2025 | https://conductscience.org/library/papers/41178713 | PubMed |
| 40988601 | Dimerization and dynamics of human angiotensin-I converting enzyme revealed by cryo-EM and MD simulations. | Elife | 2025 | https://conductscience.org/library/papers/40988601 | PubMed |
| 40952998 | ACE1 does not influence cerebral Aβ degradation or amyloid plaque accumulation in 5XFAD mice. | PLoS One | 2025 | https://conductscience.org/library/papers/40952998 | PubMed |
| 40722848 | Immunomodulatory Effects of RAAS Inhibitors: Beyond Hypertension and Heart Failure. | Biomedicines | 2025 | https://conductscience.org/library/papers/40722848 | PubMed |
| 40490625 | Boosting angiotensin-converting enzyme (ACE) in microglia protects against Alzheimer's disease in 5xFAD mice. | Nat Aging | 2025 | https://conductscience.org/library/papers/40490625 | PubMed |
| 40186068 | Associations among Angiotensin-Converting Enzyme, Neuroinflammation, and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease in Non-Dementia Adults. | Neurotox Res | 2025 | https://conductscience.org/library/papers/40186068 | PubMed |
| 40047999 | Perturbations in the neuroactive ligand-receptor interaction and renin angiotensin system pathways are associated with cancer-related cognitive impairment. | Support Care Cancer | 2025 | https://conductscience.org/library/papers/40047999 | PubMed |
| 39572624 | A randomized clinical trial evaluating Hydralazine's efficacy in early-stage Alzheimer's disease: The EHSAN Study. | Sci Rep | 2024 | https://conductscience.org/library/papers/39572624 | PubMed |
| 39160618 | Trajectory of brain-derived amyloid beta in Alzheimer's disease: where is it coming from and where is it going? | Transl Neurodegener | 2024 | https://conductscience.org/library/papers/39160618 | PubMed |
| 39114703 | Mathematical modelling of Alzheimer's disease biomarkers: Targeting Amyloid beta, Tau protein, Apolipoprotein E and Apoptotic pathways. | Am J Transl Res | 2024 | https://conductscience.org/library/papers/39114703 | PubMed |
| 38137453 | Contextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer's Disease. | Biomedicines | 2023 | https://conductscience.org/library/papers/38137453 | PubMed |
| 37928535 | Myeloid cell ACE shapes cellular metabolism and function in PCSK-9 induced atherosclerosis. | Front Immunol | 2023 | https://conductscience.org/library/papers/37928535 | PubMed |
| 37630190 | Utilizing Proteomic Approaches to Uncover the Neuroprotective Effects of ACE Inhibitors: Implications for Alzheimer's Disease Treatment. | Molecules | 2023 | https://conductscience.org/library/papers/37630190 | PubMed |
| 37440496 | A novel co-culture model for investigation of the effects of LPS-induced macrophage-derived cytokines on brain endothelial cells. | PLoS One | 2023 | https://conductscience.org/library/papers/37440496 | PubMed |
| 37427403 | The effects of enhancing angiotensin converting enzyme in myelomonocytes on ameliorating Alzheimer's-related disease and preserving cognition. | Front Physiol | 2023 | https://conductscience.org/library/papers/37427403 | PubMed |
| 37325640 | Osteopontin depletion in macrophages perturbs proteostasis via regulating UCHL1-UPS axis and mitochondria-mediated apoptosis. | Front Immunol | 2023 | https://conductscience.org/library/papers/37325640 | PubMed |
| 37225143 | Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor α and fundamentally changing lipid metabolism. | Cardiovasc Res | 2023 | https://conductscience.org/library/papers/37225143 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24487585
GET https://conductscience.org/api/papers/v1/24487585/references?page=2